Shield Therapeutics plc (SHIELD THERAPEUTICS PLC ORD 1.5) aktie
STX.L
£5.75-0.10 (-1.71%)
Laddar diagram...
SHIELD THERAPEUTICS PLC ORD 1.5
Market Cap
$61,497,636
Öppning0.00
Högsta0.00
Lägsta0.00
Volym50k
P/EN/A
Börsvärde61.5M
52 veckors högsta12.50
52 veckors lägsta0.00
Genomsnittlig volym2.56M
UtdelningN/A
Beta1.88
EPS-0.01
Om Shield Therapeutics plc (SHIELD THERAPEUTICS PLC ORD 1.5) aktie
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Företagsinformation
Börs: LSE (LSE)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adress:
Northern Design Centre
NE8 3DF Gateshead, United Kingdom
NE8 3DF Gateshead, United Kingdom
Telefon: + 44 1915 118 500
Hemsida: https://www.shieldtherapeutics.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Lägsta kursmål
14.00
↑ 143.5%
Genomsnittligt kursmål
17.33
↑ 201.4%
Median kursmål
15.00
↑ 160.9%
Högsta kursmål
23.00
↑ 300.0%